Zomedica Corp. Payments to Acquire Other Productive Assets
Zomedica Corp. (ZOMDF) reported Payments to Acquire Other Productive Assets of $10.84 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherProductiveAssets · last filed 2024-04-01
- Zomedica Corp. payments to acquire other productive assets for the quarter ending 2023-12-31 was $1.92M, a 291.84% increase year-over-year.
- Zomedica Corp. payments to acquire other productive assets for the quarter ending 2023-09-30 was $6.23M, a 697.06% increase year-over-year.
- Zomedica Corp. payments to acquire other productive assets for the quarter ending 2023-06-30 was $1.83M, a 396.75% increase year-over-year.
- Zomedica Corp. payments to acquire other productive assets for the quarter ending 2023-03-31 was $857.00K, a 596.75% increase year-over-year.
- Zomedica Corp. payments to acquire other productive assets for fiscal 2023 was $10.84M, a 514.68% increase from fiscal 2022.
- Zomedica Corp. payments to acquire other productive assets for fiscal 2022 was $1.76M.
| Period end | Payments to Acquire Other Productive Assets 3 month | Payments to Acquire Other Productive Assets 6 month | Payments to Acquire Other Productive Assets 9 month | Payments to Acquire Other Productive Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $8.15M derived: sum of 2 quarters · filed 2024-04-01 | $9.99M derived: sum of 3 quarters · filed 2024-04-01 | $10.84M 10-K · filed 2024-04-01 |
| 2023-09-30 | $6.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $8.07M derived: sum of 2 quarters · filed 2023-11-13 | $8.92M 10-Q · filed 2023-11-13 | $9.41M derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.69M 10-Q · filed 2023-08-10 | $3.18M derived: sum of 3 quarters · filed 2024-04-01 | $3.96M derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-03-31 | $857.00K 10-Q · filed 2023-05-11 | $1.35M derived: sum of 2 quarters · filed 2024-04-01 | $2.13M derived: sum of 3 quarters · filed 2024-04-01 | $2.50M derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-12-31 | $490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.27M derived: sum of 2 quarters · filed 2024-04-01 | $1.64M derived: sum of 3 quarters · filed 2024-04-01 | $1.76M 10-K · filed 2024-04-01 |
| 2022-09-30 | $782.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.15M derived: sum of 2 quarters · filed 2023-11-13 | $1.27M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $492.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $123.00K 10-Q · filed 2023-05-11 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 |